Literature DB >> 17057735

Transforming growth factor alpha promotes sequential conversion of mature astrocytes into neural progenitors and stem cells.

A Sharif1, P Legendre, V Prévot, C Allet, L Romao, J-M Studler, H Chneiweiss, M-P Junier.   

Abstract

An instability of the mature cell phenotype is thought to participate to the formation of gliomas, primary brain tumors deriving from astrocytes and/or neural stem cells. Transforming growth factor alpha (TGFalpha) is an erbB1 ligand overexpressed in the earliest stages of gliomas, and exerts trophic effects on gliomal cells and astrocytes. Here, we questioned whether prolonged TGFalpha exposure affects the stability of the normal mature astrocyte phenotype. We first developed astrocyte cultures devoid of residual neural stem cells or progenitors. We demonstrate that days of TGFalpha treatment result in the functional conversion of a population of mature astrocytes into radial glial cells, a population of neural progenitors. TGFalpha-generated radial glial cells support embryonic neurons migration, and give birth to cells of the neuronal lineage, expressing neuronal markers and the electrophysiological properties of neuroblasts. Lengthening TGFalpha treatment to months results in the delayed appearance of cells with neural stem cells properties: they form floating cellular spheres that are self-renewing, can be clonally derived from a single cell and differentiated into cells of the neuronal lineage. This study uncovers a novel population of mature astrocytes capable, in response to a single epigenetic factor, to regress progressively into a neural stem-like cell stage via an intermediate progenitor stage.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17057735     DOI: 10.1038/sj.onc.1210071

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  28 in total

Review 1.  The cancer stem cell paradigm: a new understanding of tumor development and treatment.

Authors:  Johnathan D Ebben; Daniel M Treisman; Michael Zorniak; Raman G Kutty; Paul A Clark; John S Kuo
Journal:  Expert Opin Ther Targets       Date:  2010-06       Impact factor: 6.902

Review 2.  Astrocytes, therapeutic targets for neuroprotection and neurorestoration in ischemic stroke.

Authors:  Zhongwu Liu; Michael Chopp
Journal:  Prog Neurobiol       Date:  2015-10-09       Impact factor: 11.685

3.  Reinduction of ErbB2 in astrocytes promotes radial glial progenitor identity in adult cerebral cortex.

Authors:  H T Ghashghaei; Jill M Weimer; Ralf S Schmid; Yukako Yokota; Ken D McCarthy; Brian Popko; E S Anton
Journal:  Genes Dev       Date:  2007-12-15       Impact factor: 11.361

4.  Transforming growth factor α transforms astrocytes to a growth-supportive phenotype after spinal cord injury.

Authors:  Robin E White; Meghan Rao; John C Gensel; Dana M McTigue; Brian K Kaspar; Lyn B Jakeman
Journal:  J Neurosci       Date:  2011-10-19       Impact factor: 6.167

5.  Schwann cells can be reprogrammed to multipotency by culture.

Authors:  Darius Widera; Peter Heimann; Christin Zander; Yvonne Imielski; Meike Heidbreder; Mike Heilemann; Christian Kaltschmidt; Barbara Kaltschmidt
Journal:  Stem Cells Dev       Date:  2011-06-01       Impact factor: 3.272

Review 6.  Role of inflammation and its mediators in acute ischemic stroke.

Authors:  Rong Jin; Lin Liu; Shihao Zhang; Anil Nanda; Guohong Li
Journal:  J Cardiovasc Transl Res       Date:  2013-09-05       Impact factor: 4.132

Review 7.  Therapeutical Strategies for Spinal Cord Injury and a Promising Autologous Astrocyte-Based Therapy Using Efficient Reprogramming Techniques.

Authors:  Hao Yang; Cui-Cui Liu; Chun-Yu Wang; Qian Zhang; Jiang An; Lingling Zhang; Ding-Jun Hao
Journal:  Mol Neurobiol       Date:  2015-04-12       Impact factor: 5.590

8.  Differential distribution of erbB receptors in human glioblastoma multiforme: expression of erbB3 in CD133-positive putative cancer stem cells.

Authors:  Véronique Duhem-Tonnelle; Ivan Bièche; Sophie Vacher; Anne Loyens; Claude-Alain Maurage; Francis Collier; Marc Baroncini; Serge Blond; Vincent Prevot; Ariane Sharif
Journal:  J Neuropathol Exp Neurol       Date:  2010-06       Impact factor: 3.685

9.  CD133, CD15/SSEA-1, CD34 or side populations do not resume tumor-initiating properties of long-term cultured cancer stem cells from human malignant glio-neuronal tumors.

Authors:  Cristina Patru; Luciana Romao; Pascale Varlet; Laure Coulombel; Eric Raponi; Josette Cadusseau; François Renault-Mihara; Cécile Thirant; Nadine Leonard; Alain Berhneim; Maria Mihalescu-Maingot; Jacques Haiech; Ivan Bièche; Vivaldo Moura-Neto; Catherine Daumas-Duport; Marie-Pierre Junier; Hervé Chneiweiss
Journal:  BMC Cancer       Date:  2010-02-24       Impact factor: 4.430

Review 10.  Activated epidermal growth factor receptor in ovarian cancer.

Authors:  Laurie G Hudson; Reema Zeineldin; Melina Silberberg; M Sharon Stack
Journal:  Cancer Treat Res       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.